SARS-CoV-2 nucleoprotein can trigger α-synuclein amyloid fibril formation

The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a primarily respiratory virus. It is the causative agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic. In severe or critical cases, however, this virus is known to trigger rapid and severe deterioration of multiple organs, including the central nervous system. […]

Research looks at SARS-CoV-2 transmission from people to pets

A large team of researchers from the US demonstrated that pets with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) likely acquired the putative virus from humans.  This suggests that human-animal infection may actually occur much more frequently than previously thought – implying that infected individuals should limit their contact […]

Statins improve 28-day mortality in hospitalized COVID-19 patients

Amid the coronavirus disease (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), people with comorbidities are at a higher risk of developing severe disease. In the fight against COVID-19, scientists are racing to determine effective treatments to reduce mortality among infected individuals. Now, researchers at Harvard Medical […]

Mouse monoclonal antibodies protect against SARS-CoV-2 wildtype, UK and South African variants

The importance of cross-neutralizing antibodies to the recently emerged variants of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is evident in light of the fact that these variants are highly transmissible as well as being able to evade immune responses to earlier variants of this virus. A new preprint […]

Novel polyclonal antibody XAV-19 efficiently neutralizes UK and South African SARS-CoV-2 variants

A promising new study, released as a preprint on the bioRxiv* server, reports on the high neutralizing efficacy of a polyclonal swine antibody against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the pathogen responsible for the novel coronavirus disease 2019 (COVID-19). By demonstrating the ability of this antibody to […]